Achilles Therapeutics plc

NASDAQ: ACHL- / - / -
12.01-0.6000-4.76%Vol 30.26K1Y Perf -24.59%
Jun 14th, 2021 16:00 DELAYED
BID12.10 ASK12.26
Open12.75 Previous Close12.61
Pre-Market- After-Market-
 - -  - -%
Target Price
21.20 
Analyst Rating
— — 0.00
Potential %
76.52 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap487.87M 
Earnings Rating
Price Range Ratio 52W %
0.00 
Earnings Date
-

Today's Price Range

12.0112.75

52W Range

12.0118.95

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-5.66%
1 Month
-7.83%
3 Months
-
6 Months
-
1 Year
-24.59%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ACHL12.01-0.6000-4.76
AAPL130.483.13002.46
GOOG2 527.0413.11000.52
MSFT259.892.00000.78
XOM62.07-0.1000-0.16
WFC45.15-0.5300-1.16
JNJ165.370.41000.25
FB336.775.51001.66
GE13.47-0.2200-1.61
JPM157.57-2.7200-1.70
Earnings HistoryEstimateReportedSurprise %
Q01 2021-3.04-8.38-175.66
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume30.26K
Shares Outstanding40.62M
Trades Count206
Dollar Volume0
Avg. Volume63.25K
Avg. Weekly Volume12.16K
Avg. Monthly Volume10.47K
Avg. Quarterly Volume63.25K

Achilles Therapeutics plc (NASDAQ: ACHL) stock closed at 12.01 per share at the end of the most recent trading day (a -4.76% change compared to the prior day closing price) with a volume of 130.26K shares and market capitalization of 487.87M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the industry, sector and employs 0 people. Achilles Therapeutics plc CEO is .

The one-year performance of Achilles Therapeutics plc stock is -24.59%, while year-to-date (YTD) performance is %. ACHL stock has a five-year performance of %. Its 52-week range is between 12.01 and 18.95, which gives ACHL stock a 52-week price range ratio of 0.00%

Achilles Therapeutics plc currently has a PE ratio of -1.80, a price-to-book (PB) ratio of 2.86, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -20.26%, a ROC of -21.43% and a ROE of -23.33%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Achilles Therapeutics plc, there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Achilles Therapeutics plc’s next earnings report date is -.

The consensus rating of Wall Street analysts for Achilles Therapeutics plc is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Achilles Therapeutics plc stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Achilles Therapeutics plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Achilles Therapeutics plc has a Neutral technical analysis rating based on Technical Indicators (ADX : 12.08, ATR14 : 0.64, CCI20 : -162.75, Chaikin Money Flow : -0.69, MACD : -0.43, Money Flow Index : 4.76, ROC : -6.25, RSI : 34.81, STOCH (14,3) : 0.00, STOCH RSI : 0.00, UO : 27.29, Williams %R : -100.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Achilles Therapeutics plc in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Achilles Therapeutics plc

CEO:

Telephone:

Address: , , ,

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

63%38%

Bearish Bullish

67%33%

News

Stocktwits